Assessing the neuroprotective benefits of Cannabis sativa in epilepsy management

Abstract

Epilepsy is one of the most common neurological conditions worldwide. Cannabinoids, particularly cannabidiol (CBD) and tetrahydrocannabinol (THC), have demonstrated therapeutic potential in the treatment of epilepsy due to their interaction with the endocannabinoids system. Despite these developments, the use of medical cannabis is still complicated because of legal obstacles, the different psychoactive effects of different cannabinoid receptors, and concerns about long-term safety, especially in populations with young children. The development of new regulations will be essential to increasing access to patients' cannabis medications. Cannabis has the potential to change the therapeutic landscape for neurological illnesses like seizures, provided that science and regulation continue to progress.

Keywords

• Cannabis sativa
• Cannabinoids
• Cannabidiol (CBD)
• Tetrahydrocannabinol (THC)
• Epilepsy
• Drug-resistant epilepsy